IndustryPayments
Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

RICHARD H PATT

Allopathic & Osteopathic Physicians Radiology Diagnostic Radiology

NPI
1558356758
CMS profile
1147947
Location
WARMINSTER, PA

General Payments · PY2021–2024

$65,871.25

  • Reported across 54 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$31,972.50

49 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

Related groups: Diagnostic Radiology PA All categories

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Consulting Fee $31,972.50 49

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Regeneron Pharmaceuticals, Inc. $21,247.50 47
ABBVIE INC. $10,725.00 2

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2021 $19,451.25 1
PY2022 $9,360.00 2
PY2023 $5,087.50 2
PY2024 $31,972.50 49

Payment records · PY2024 (49)

Sorted by paying entity, then date · as published by CMS

Program year 2024 202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $7,975.00 12/11/2024 Consulting Fee Undisputed 01/23/2026 1105210898 CMS
ABBVIE INC. $2,750.00 12/11/2024 Consulting Fee Undisputed 01/23/2026 1105210902 CMS
Regeneron Pharmaceuticals, Inc. $585.00 11/06/2024 Consulting Fee Undisputed 01/23/2026 1114403485 CMS
Regeneron Pharmaceuticals, Inc. $585.00 11/06/2024 Consulting Fee Undisputed 01/23/2026 1114403487 CMS
Regeneron Pharmaceuticals, Inc. $1,462.50 11/06/2024 Consulting Fee Undisputed 01/23/2026 1114403489 CMS
Regeneron Pharmaceuticals, Inc. $510.00 11/08/2024 Consulting Fee Undisputed 01/23/2026 1114403491 CMS
Regeneron Pharmaceuticals, Inc. $510.00 11/08/2024 Consulting Fee Undisputed 01/23/2026 1114403493 CMS
Regeneron Pharmaceuticals, Inc. $510.00 11/08/2024 Consulting Fee Undisputed 01/23/2026 1114403495 CMS
Regeneron Pharmaceuticals, Inc. $510.00 11/08/2024 Consulting Fee Undisputed 01/23/2026 1114403497 CMS
Regeneron Pharmaceuticals, Inc. $510.00 11/08/2024 Consulting Fee Undisputed 01/23/2026 1114403499 CMS
Regeneron Pharmaceuticals, Inc. $510.00 11/08/2024 Consulting Fee Undisputed 01/23/2026 1114403501 CMS
Regeneron Pharmaceuticals, Inc. $765.00 11/08/2024 Consulting Fee Undisputed 01/23/2026 1114403503 CMS
Regeneron Pharmaceuticals, Inc. $255.00 11/08/2024 Consulting Fee Undisputed 01/23/2026 1114403505 CMS
Regeneron Pharmaceuticals, Inc. $255.00 11/08/2024 Consulting Fee Undisputed 01/23/2026 1114403507 CMS
Regeneron Pharmaceuticals, Inc. $255.00 11/08/2024 Consulting Fee Undisputed 01/23/2026 1114403509 CMS
Regeneron Pharmaceuticals, Inc. $255.00 11/08/2024 Consulting Fee Undisputed 01/23/2026 1114403511 CMS
Regeneron Pharmaceuticals, Inc. $255.00 11/08/2024 Consulting Fee Undisputed 01/23/2026 1114403513 CMS
Regeneron Pharmaceuticals, Inc. $255.00 11/08/2024 Consulting Fee Undisputed 01/23/2026 1114403515 CMS
Regeneron Pharmaceuticals, Inc. $510.00 11/08/2024 Consulting Fee Undisputed 01/23/2026 1114403517 CMS
Regeneron Pharmaceuticals, Inc. $255.00 11/08/2024 Consulting Fee Undisputed 01/23/2026 1114403519 CMS
Regeneron Pharmaceuticals, Inc. $510.00 11/08/2024 Consulting Fee Undisputed 01/23/2026 1114403521 CMS
Regeneron Pharmaceuticals, Inc. $510.00 11/08/2024 Consulting Fee Undisputed 01/23/2026 1114403523 CMS
Regeneron Pharmaceuticals, Inc. $510.00 11/08/2024 Consulting Fee Undisputed 01/23/2026 1114403525 CMS
Regeneron Pharmaceuticals, Inc. $255.00 11/08/2024 Consulting Fee Undisputed 01/23/2026 1114403527 CMS
Regeneron Pharmaceuticals, Inc. $510.00 11/08/2024 Consulting Fee Undisputed 01/23/2026 1114403529 CMS
Regeneron Pharmaceuticals, Inc. $510.00 11/08/2024 Consulting Fee Undisputed 01/23/2026 1114403531 CMS
Regeneron Pharmaceuticals, Inc. $510.00 11/08/2024 Consulting Fee Undisputed 01/23/2026 1114403533 CMS
Regeneron Pharmaceuticals, Inc. $510.00 11/08/2024 Consulting Fee Undisputed 01/23/2026 1114403535 CMS
Regeneron Pharmaceuticals, Inc. $255.00 11/08/2024 Consulting Fee Undisputed 01/23/2026 1114403537 CMS
Regeneron Pharmaceuticals, Inc. $510.00 11/08/2024 Consulting Fee Undisputed 01/23/2026 1114403539 CMS
Regeneron Pharmaceuticals, Inc. $255.00 11/08/2024 Consulting Fee Undisputed 01/23/2026 1114403541 CMS
Regeneron Pharmaceuticals, Inc. $765.00 11/08/2024 Consulting Fee Undisputed 01/23/2026 1114403543 CMS
Regeneron Pharmaceuticals, Inc. $765.00 11/08/2024 Consulting Fee Undisputed 01/23/2026 1114403545 CMS
Regeneron Pharmaceuticals, Inc. $510.00 11/08/2024 Consulting Fee Undisputed 01/23/2026 1114403547 CMS
Regeneron Pharmaceuticals, Inc. $510.00 11/08/2024 Consulting Fee Undisputed 01/23/2026 1114403549 CMS
Regeneron Pharmaceuticals, Inc. $510.00 11/08/2024 Consulting Fee Undisputed 01/23/2026 1114403551 CMS
Regeneron Pharmaceuticals, Inc. $765.00 11/08/2024 Consulting Fee Undisputed 01/23/2026 1114403553 CMS
Regeneron Pharmaceuticals, Inc. $255.00 11/08/2024 Consulting Fee Undisputed 01/23/2026 1114403555 CMS
Regeneron Pharmaceuticals, Inc. $510.00 11/08/2024 Consulting Fee Undisputed 01/23/2026 1114403557 CMS
Regeneron Pharmaceuticals, Inc. $255.00 11/08/2024 Consulting Fee Undisputed 01/23/2026 1114403559 CMS
Regeneron Pharmaceuticals, Inc. $510.00 11/08/2024 Consulting Fee Undisputed 01/23/2026 1114403561 CMS
Regeneron Pharmaceuticals, Inc. $255.00 11/08/2024 Consulting Fee Undisputed 01/23/2026 1114403563 CMS
Regeneron Pharmaceuticals, Inc. $255.00 11/08/2024 Consulting Fee Undisputed 01/23/2026 1114403565 CMS
Regeneron Pharmaceuticals, Inc. $255.00 11/08/2024 Consulting Fee Undisputed 01/23/2026 1114403567 CMS
Regeneron Pharmaceuticals, Inc. $255.00 11/08/2024 Consulting Fee Undisputed 01/23/2026 1114403569 CMS
Regeneron Pharmaceuticals, Inc. $255.00 11/08/2024 Consulting Fee Undisputed 01/23/2026 1114403571 CMS
Regeneron Pharmaceuticals, Inc. $255.00 11/08/2024 Consulting Fee Undisputed 01/23/2026 1114403573 CMS
Regeneron Pharmaceuticals, Inc. $255.00 11/08/2024 Consulting Fee Undisputed 01/23/2026 1114403575 CMS
Regeneron Pharmaceuticals, Inc. $510.00 11/08/2024 Consulting Fee Undisputed 01/23/2026 1114403577 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.